Bold claim: Brain-gut behavioral therapies can meaningfully ease global IBS symptoms in many adults, and this is supported by a large, comprehensive analysis. But here’s where it gets controversial: the strength and certainty of the evidence vary, and not all therapies shine equally across studies. In this review, researchers compared a wide range of behavioral approaches that target brain-gut connections, including IBS-specific cognitive behavioral therapy (CBT) and gut-directed hypnotherapy, against other behavioral or digital interventions that aren’t classified as brain-gut therapies. Their goal was to see which methods most consistently improve overall IBS symptoms in adults.
Overview of approach: The team conducted a systematic search of major medical and psychology databases up to April 23, 2025, then ran a network meta-analysis of randomized controlled trials. Trials compared one therapy against another or against control conditions. The outcome measure was a global assessment of IBS symptom improvement at the first follow-up after treatment, using dichotomous (yes/no) improvement criteria. Relative risks (RRs) were calculated, and therapies were ranked with P scores to indicate the probability that one intervention outperforms another when considering all eligible therapies.
Key findings: Across 67 trials including 7,441 adults with IBS, several behavioral therapies showed significant improvements over waiting-list controls at the first post-treatment follow-up. The top performers, based on pooled RRs and ranking, included:
- Minimal-contact CBT (RR for lack of improvement at follow-up: 0.55; 95% CI 0.39–0.76; P score 0.78; 2 trials; 511 participants)
- Telephone-based disease self-management (RR 0.57; 95% CI 0.41–0.80; P score 0.75; 2 trials; 746 participants)
- Dynamic psychotherapy (RR 0.59; 95% CI 0.43–0.80; P score 0.72; 3 trials; 303 participants)
- Standard CBT (RR 0.65; 95% CI 0.53–0.80; P score 0.64; 9 trials; 1,150 participants)
Other effective options included disease self-management (RR 0.68; 95% CI 0.50–0.92; 3 trials; 375 participants), internet-based minimal-contact CBT (RR 0.77; 95% CI 0.61–0.96; 5 trials; 705 participants), and gut-directed hypnotherapy (RR 0.79; 95% CI 0.66–0.95; 12 trials; 1,507 participants).
For patients with treatment-refractory IBS, several therapies remained beneficial compared with both attention control and routine care: telephone-based disease self-management and contingency management demonstrated superiority, as did group CBT, internet-based disease self-management, and dynamic psychotherapy. Specific numbers illustrate reductions in the risk of non-improvement relative to these controls, spanning RR values roughly from 0.45 to 0.58 across refractory populations.
Caveats about study quality: The analysis noted potential publication bias when therapies were grouped by class or compared with waiting lists. None of the included trials achieved a low risk of bias across all methodological domains using the Cochrane risk-of-bias tool. Consequently, while several behavioral therapies show promise, the overall certainty of evidence across direct and indirect comparisons is rated as low to very low.
Bottom line from the researchers: The strongest evidence for improving global IBS symptoms during brain-gut–oriented behavioral therapies points to CBT-based approaches, disease self-management strategies, dynamic psychotherapy, and gut-directed hypnotherapy. There appears to be less robust support for behavioral therapies outside the brain-gut framework, though some stress-management methods may still outperform waiting-list controls, and digital gut-directed hypnotherapy shows potential in large trials.
Thought-starters: Do these findings shift how you’d approach IBS treatment—prioritizing cognitive-behavioral and self-management strategies before more invasive options? How would you weigh the relatively lower certainty of evidence against the noticeable benefits seen in several trials? Share your perspective below to join the discussion.
